NeueHealth
NEUE
NEUE was delisted on the 1st of October, 2025.
38 hedge funds and large institutions have $35.3M invested in NeueHealth in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.28% less ownership
Funds ownership: 59% → 58.72% (-0.28%)
3% less capital invested
Capital invested by funds: $36.3M → $35.3M (-$1M)
5% less funds holding
Funds holding: 40 → 38 (-2)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$168K |
| 2 |
DTL
Dynamic Technology Lab
Singapore
|
+$134K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.06K |
| 4 |
BlackRock
New York
|
+$2.92K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$44.8K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$44.4K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.37K |
| 4 |
MS
Marshall & Sullivan
Seattle,
Washington
|
-$2.59K |
| 5 |
Morgan Stanley
New York
|
-$2.29K |
NEUE Hedge Fund Activity: Q3 2025 in Review
38 of the 7,638 institutional investors tracked by Wall St. Rank reported a position in NeueHealth (NEUE) for Q3 2025, worth a combined $35.3M — down 2.8% from $36.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NEUE and 3 opened new positions — a net loss of 2 holders — while 7 trimmed existing stakes and 6 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $168K. The largest seller was UBS Group, cutting an estimated $44.8K.
- 38 institutional investors held NeueHealth (NEUE) as of Q3 2025, down from 40 in Q2 2025.
- Funds reported $35.3M of NeueHealth stock for Q3 2025, down 2.8% quarter-over-quarter.
- 3 funds opened new NeueHealth positions in Q3 2025 and 5 closed out, a net change of -2 holders.
- The largest NeueHealth buyer in Q3 2025 was Susquehanna International Group, an estimated $168K added.
- The largest NeueHealth seller in Q3 2025 was UBS Group, an estimated $44.8K sold.
Based on aggregated 13F filings for Q3 2025.